A Topic Working Group comprised of individuals with relevant expertise in the management of heavy menstrual bleeding, and experience in the Australian health care system as well as representatives of major consumer organisations, was convened to provide clinical advice, expertise and consumer input to this work.
Topic Working Group
All members are required to disclose financial, personal and professional interests that could, or could be perceived to, influence a decision made, or advice given to the Commission. Disclosures are updated prior to each meeting and managed in line with the Commission’s Policy on Disclosure of Interests.
The Heavy Menstrual Bleeding Clinical Care Standard aims to ensure that women with heavy menstrual bleeding are offered the least invasive and most effective treatment appropriate to their clinical needs, and have the opportunity to make an informed choice from the range of treatments suitable to their individual situation.
The Heavy Menstrual Bleeding Clinical Care Standard provides advice to clinicians, consumers and health services on key components of care including:
- Assessment and diagnosis
- Informed choice and shared decision making
- Initial treatment is pharmaceutical
- Quality ultrasound
- Intra-uterine hormonal devices
- Specialist referral
- Uterine-preserving alternatives to hysterectomy
The Commission undertook a public consultation on the draft Heavy Menstrual Bleeding Clinical Care Standard and related documentation from 23 November 2016 to 11 January 2017. Submissions were received from a range of stakeholders including individuals, professional and peak organisations, hospitals and other health services.